222
Views
11
CrossRef citations to date
0
Altmetric
CELLULAR AND MOLECULAR BIOLOGY

An Analog of Withaferin A Activates the MAPK and Glutathione “Stress” Pathways and Inhibits Pancreatic Cancer Cell Proliferation

, , , , , , & show all
Pages 668-675 | Published online: 15 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zhichao Xing, Anping Su, Li Mi, Yujie Zhang, Ting He, Yuxuan Qiu, Tao Wei, Zhihui Li, Jingqiang Zhu & Wenshuang Wu. (2023) Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms. Drug Design, Development and Therapy 17, pages 2909-2929.
Read now

Articles from other publishers (10)

Qi Shao, Yechen Feng, Wenwu Wang, Min Wang, Binbin Li, Mario El Tahchi & Yixia Yin. (2019) Drug carrier for sustained release of withaferin A for pancreatic cancer treatment. Journal of Materials Science 55:4, pages 1702-1714.
Crossref
Rui Guo, Lu Gan, Wayne Bond Lau, Zheyi Yan, Dina Xie, Erhe Gao, Theodore A Christopher, Bernard L. Lopez, Xinliang Ma & Yajing Wang. (2019) Withaferin A Prevents Myocardial Ischemia/Reperfusion Injury by Upregulating AMP-Activated Protein Kinase-Dependent B-Cell Lymphoma2 Signaling. Circulation Journal 83:8, pages 1726-1736.
Crossref
E. M. Kithsiri Wijeratne, Maria C. F. Oliveira, Jair Mafezoli, Ya-Ming Xu, Sandro Minguzzi, Pedro H. J. Batista, Otília D. L. Pessoa, Luke Whitesell & A. A. Leslie Gunatilaka. (2018) Withaferin A and Withanolide D Analogues with Dual Heat-Shock-Inducing and Cytotoxic Activities: Semisynthesis and Biological Evaluation. Journal of Natural Products 81:4, pages 825-837.
Crossref
Prasanna K. Santhekadur. (2017) Is Withaferin A, a magic bullet for metabolic syndrome?. Biomedicine & Pharmacotherapy 92, pages 1135-1137.
Crossref
Ya-Ming Xu, Alan D. Brooks, E. M. Kithsiri Wijeratne, Curtis J. Henrich, Poonam Tewary, Thomas J. Sayers & A. A. Leslie Gunatilaka. (2017) 17β-Hydroxywithanolides as Sensitizers of Renal Carcinoma Cells to Tumor Necrosis Factor-α Related Apoptosis Inducing Ligand (TRAIL) Mediated Apoptosis: Structure–Activity Relationships. Journal of Medicinal Chemistry 60:7, pages 3039-3051.
Crossref
Mahima Vedi & Evan Prince Sabina. (2016) Assessment of hepatoprotective and nephroprotective potential of withaferin A on bromobenzene-induced injury in Swiss albino mice: possible involvement of mitochondrial dysfunction and inflammation. Cell Biology and Toxicology 32:5, pages 373-390.
Crossref
Ya-Ming Xu, Manping X. Liu, Nathan Grunow, E. M. Kithsiri Wijeratne, Gillian Paine-Murrieta, Stephen Felder, Richard M. Kris & A. A. Leslie Gunatilaka. (2015) Discovery of Potent 17β-Hydroxywithanolides for Castration-Resistant Prostate Cancer by High-Throughput Screening of a Natural Products Library for Androgen-Induced Gene Expression Inhibitors. Journal of Medicinal Chemistry 58:17, pages 6984-6993.
Crossref
E. M. Kithsiri Wijeratne, Ya-Ming Xu, Ruth Scherz-Shouval, Marilyn T. Marron, Danilo D. Rocha, Manping X. Liu, Leticia V. Costa-Lotufo, Sandro Santagata, Susan Lindquist, Luke Whitesell & A. A. Leslie Gunatilaka. (2014) Structure–Activity Relationships for Withanolides as Inducers of the Cellular Heat-Shock Response. Journal of Medicinal Chemistry 57:7, pages 2851-2863.
Crossref
Kanika Patel, Ravi B Singh & Dinesh K Patel. (2013) Pharmacological and analytical aspects of withaferin A: A concise report of current scientific literature. Asian Pacific Journal of Reproduction 2:3, pages 238-243.
Crossref
Wim Vanden Berghe, Linde Sabbe, Mary Kaileh, Guy Haegeman & Karen Heyninck. (2012) Molecular insight in the multifunctional activities of Withaferin A. Biochemical Pharmacology 84:10, pages 1282-1291.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.